Evaluation of the immunogenicity of an mRNA vectored Nipah virus vaccine candidate in pigs

Bibliographic Details
Title: Evaluation of the immunogenicity of an mRNA vectored Nipah virus vaccine candidate in pigs
Authors: Miriam Pedrera, Rebecca K. McLean, Lobna Medfai, Nazia Thakur, Shawn Todd, Glenn Marsh, Dalan Bailey, Gaetano Donofrio, Hiromi Muramatsu, Norbert Pardi, Drew Weissman, Simon P. Graham
Source: Frontiers in Immunology, Vol 15 (2024)
Publisher Information: Frontiers Media S.A., 2024.
Publication Year: 2024
Collection: LCC:Immunologic diseases. Allergy
Subject Terms: Nipah virus, vaccine, mRNA, pig, immunogenicity, Immunologic diseases. Allergy, RC581-607
More Details: Nipah virus (NiV) poses a significant threat to human and livestock populations across South and Southeast Asia. Vaccines are required to reduce the risk and impact of spillover infection events. Pigs can act as an intermediate amplifying host for NiV and, separately, provide a preclinical model for evaluating human vaccine candidate immunogenicity. The aim of this study was therefore to evaluate the immunogenicity of an mRNA vectored NiV vaccine candidate in pigs. Pigs were immunized twice with 100 μg nucleoside-modified mRNA vaccine encoding soluble G glycoprotein from the Malaysia strain of NiV, formulated in lipid nanoparticles. Potent antigen-binding and virus neutralizing antibodies were detected in serum following the booster immunization. Antibody responses effectively neutralized both the Malaysia and Bangladesh strains of NiV but showed limited neutralization of the related (about 80% amino acid sequence identity for G) Hendra virus. Antibodies were also capable of neutralizing NiV glycoprotein mediated cell-cell fusion. NiV G-specific T cell cytokine responses were also measurable following the booster immunization with evidence for induction of both CD4 and CD8 T cell responses. These data support the further evaluation of mRNA vectored NiV G as a vaccine for both pigs and humans.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1664-3224
Relation: https://www.frontiersin.org/articles/10.3389/fimmu.2024.1384417/full; https://doaj.org/toc/1664-3224
DOI: 10.3389/fimmu.2024.1384417
Access URL: https://doaj.org/article/bf49e459295e408ab967403bef48df7c
Accession Number: edsdoj.bf49e459295e408ab967403bef48df7c
Database: Directory of Open Access Journals
More Details
ISSN:16643224
DOI:10.3389/fimmu.2024.1384417
Published in:Frontiers in Immunology
Language:English